Anna Dmoszynska, Janusz Kloczko, Malgorzata Rokicka, Andrzej Hellmann, Ivan Spicka, Joseph E. Eid. A dose exploration, phase I/II study of administration of continuous erythropoietin receptor activator once every 3 weeks in anemic patients with multiple myeloma receiving chemotherapy. Haematologica 2007;92(4):493-501; https://doi.org/10.3324/haematol.10730.